Importance: Sudden sensorineural hearing loss (SSNHL) is an otological emergency of unknown etiology. Recent reports showed that antioxidant drugs can benefit patients with SSNHL. This study attempted to evaluate the effect of adding antioxidant vitamins as an adjuvant therapy alongside with corticosteroids. Objective: To evaluate the effects of the 3 major antioxidant vitamins (A, C, and E) as an adjuvant therapy, administered with corticosteroids, for the treatment of SSNHL in adult patients (≥18 years). Data Sources: MEDLINE, EMBASE, PubMed, Web of Science and Cochrane electronic databases from January 1, 1995, through September 25, 2017. Study Selection: Published studies of adult patients who received antioxidant vitamins (A, C, E, or any combination of these vitamins) as an adjuvant therapy in addition to the regular treatment (corticosteroids) for SSNHL. Quality assessment was performed using the Cochrane Collaboration Tool for Assessing Risk of Bias. Data Extraction: Each study had a control group (conventional treatment + placebo) and a trial group (antioxidant vitamin(s) + conventional treatment). Results: From 446 manuscripts identified in the literature, 3 studies were included in the review with 279 patients. The most common vitamins used to treat SSNHL were the 3 major antioxidant vitamins A, C, and E, combined sometimes with other antioxidants such as selenium. Conclusions and Relevance: The success of the treatment is increased in patients who received antioxidant vitamins in combination with conventional therapy.

1.
Alexander TH, Harris JP: Incidence of sudden sensorineural hearing loss. Otol Neurotol 2013;34:1586-1589.
2.
Chung S-D, Chen P-Y, Lin H-C, Hung S-H: Sudden sensorineural hearing loss associated with iron-deficiency anemia: a population-based study. JAMA Otolaryngol Head Neck Surg 2014;140:417-422.
3.
Conlin AE, Parnes LS: Treatment of sudden sensorineural hearing loss. I. A systematic review. Arch Otolaryngol Head Neck Surg 2007;133:573-581.
4.
Darrat I, Ahmad N, Seidman K, Seidman MD: Auditory research involving antioxidants. Curr Opin Otolaryngol Head Neck Surg 2007;15:358-363.
5.
Goodhill V, Harris I, Brockman SJ, Hantz O: Sudden deafness and labyrinthine window ruptures: audio-vestibular observations. Ann Otol Rhinol Laryngol 1973;82:2-12.
6.
Hatano M, Uramoto N, Okabe Y, Furukawa M, Ito M: Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol 2008;128:116-121.
7.
Higgins JPT, Altman DG, Gotzsche PC, et al: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
8.
Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D: Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 2003;24:572-575.
9.
Kaya H, Koç AK, Sayın İ, et al: Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2015;272:1119-1125.
10.
Krämer OH, Baus D, Knauer SK, et al: Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev 2006;20:473-485.
11.
Lanvers-Kaminsky C, Zehnhoff-Dinnesen A, Parfitt R, Ciarimboli G: Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies. Clin Pharmacol Ther 2017;101:491-500.
12.
Okamoto M, Shitara T, Nakayama M, et al: Sudden deafness accompanied by asymptomatic mumps. Acta Otolaryngol Suppl 1994;514:45-48.
13.
Rudack C, Langer C, Stoll W, Rust S, Walter M: Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95:454-461.
14.
Ryu IY, Park SH, Park EB, Kim HJ, Kim SH, Yeo SG: Factors prognostic of season-associated sudden sensorineural hearing loss: a retrospective observational study. J Audiol Otol 2017;21:44-48.
15.
Simmons FB: Theory of membrane breaks in sudden hearing loss. Arch Otolaryngol 1968;88:41-48.
16.
WHO: Deafness and hearing loss. http://www.who.int/mediacentre/factsheets/fs300/en/ (accessed March 27, 2017).
17.
Young IS, Woodside JV: Antioxidants in health and disease. J Clin Pathol 2001;54:176-186.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.